Answer:
Transcription and translation occur simultaneously in prokaryotes.
Explanation:
Prokaryotes lack membrane-bound organelles and therefore, do not have a nucleus. Transcription and translation occur in the cytoplasm. As soon as the required length of mRNA is being formed, ribosomes join it and start the process of translation. Prokaryotic genes lack introns. The primary transcript formed by transcription in prokaryotes does not undergo splicing.
On the other hand, the process of transcription occurs in the nucleus in eukaryotes while translation occurs in the cytoplasm. The primary transcript formed by transcription in eukaryotes undergoes modifications to remove introns and to add a poly-A tail and 5' cap. Post-transcriptional modifications and spatial separation of two processes in eukaryotes result in slower translation than prokaryotes.
There is an uneven distribution of electrons between oxygen & hydrogen atoms
Answer:Tay-Sachs is an autosomal recessive disease caused by mutations in both alleles of a gene (HEXA) on chromosome 15. HEXA codes for the alpha subunit of the enzyme β-hexosaminidase A. This enzyme is found in lysosomes, organelles that break down large molecules for recycling by the cell.
Explanation:
Recombinant DNA is DNA that has been created using intelligent design methods to modify a base DNA molecule using DNA component elements from other strands of DNA of other organisms. There are a wide range of possible DNA elements that can be removed, added to or otherwise modified to produce the new recombinant form.
Recombinant DNA technology clearly is genetic engineering using intelligent design as the selection and placement of the added DNA components must be planned and precisely selected and placed to accomplish the intended result. It does not happen naturalistically.
There are numerous aspects of the growing technology of recombinant DNA that modify DNA to serve the purpose of the intelligent designers, including wide ranges of research, medicine, synthetic biology, potential commercial products and even scientific curiosity.
The right answer is false.
Angioplasty is a technique that can reopen narrowed or obstructed arteries in the heart (coronary arteries) without extensive surgery. First performed in 1977, angioplasty is now as common as coronary artery bypass graft surgery.
The treatment of arteriosclerosis is surgical or endovascular if there is a risk of life, significant functional impairment or major risk involving the life of an organ or limb.
Angioplasty is not the only surgery for this, Several surgical techniques aim at restoring the arterial lumen or irrigating the private territory or at suppressing the arterial aneurysm.
- Endoluminal angioplasty or dilation using a balloon with or without a stent to correct a stenosis or to recanalize a short arterial occlusion.
- The removal by endarterectomy which consists of removing the atheroma plug which obstructs an artery leaving only the weed.
- Bridging, which will "short circuit" the obliterated artery by allowing the passage of blood from the healthy artery upstream to the permeable artery downstream, made with venous, arterial or prosthetic material.
In case of an aneurysm two techniques are available: either bypass surgery in conventional surgery removing the aneurysm - or the stent covered excluding the aneurysm.
In all cases the risks must be compared to the benefits of each technique and correctly exposed beforehand. Each act must be adapted to each case according to the functional stage, the general state of the patient and his physiological age more than legal.
